X-16832646-T-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_018360.3(TXLNG):āc.888T>Gā(p.His296Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000703 in 1,209,188 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 21 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000036 ( 0 hom., 0 hem., cov: 23)
Exomes š: 0.000074 ( 0 hom. 21 hem. )
Consequence
TXLNG
NM_018360.3 missense
NM_018360.3 missense
Scores
3
1
13
Clinical Significance
Conservation
PhyloP100: 0.0990
Genes affected
TXLNG (HGNC:18578): (taxilin gamma) This gene encodes a member of the taxilin family. The encoded protein binds to the C-terminal coiled-coil region of syntaxin family members 1A, 3A and 4A, and may play a role in intracellular vesicle trafficking. This gene is up-regulated by lipopolysaccharide and the gene product may be involved in cell cycle regulation. The related mouse protein was also shown to inhibit activating transcription factor 4-mediated transcription and thus regulate bone mass accrual. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.17171198).
BS2
High Hemizygotes in GnomAdExome4 at 21 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TXLNG | NM_018360.3 | c.888T>G | p.His296Gln | missense_variant | 6/10 | ENST00000380122.10 | NP_060830.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TXLNG | ENST00000380122.10 | c.888T>G | p.His296Gln | missense_variant | 6/10 | 1 | NM_018360.3 | ENSP00000369465 | P1 | |
TXLNG | ENST00000398155.4 | c.492T>G | p.His164Gln | missense_variant | 4/8 | 1 | ENSP00000381222 |
Frequencies
GnomAD3 genomes AF: 0.0000358 AC: 4AN: 111887Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34083
GnomAD3 genomes
AF:
AC:
4
AN:
111887
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34083
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000387 AC: 7AN: 181104Hom.: 0 AF XY: 0.0000152 AC XY: 1AN XY: 65622
GnomAD3 exomes
AF:
AC:
7
AN:
181104
Hom.:
AF XY:
AC XY:
1
AN XY:
65622
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000738 AC: 81AN: 1097301Hom.: 0 Cov.: 30 AF XY: 0.0000579 AC XY: 21AN XY: 362693
GnomAD4 exome
AF:
AC:
81
AN:
1097301
Hom.:
Cov.:
30
AF XY:
AC XY:
21
AN XY:
362693
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000358 AC: 4AN: 111887Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34083
GnomAD4 genome
AF:
AC:
4
AN:
111887
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34083
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 24, 2024 | The c.888T>G (p.H296Q) alteration is located in exon 6 (coding exon 6) of the TXLNG gene. This alteration results from a T to G substitution at nucleotide position 888, causing the histidine (H) at amino acid position 296 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;.
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;.
MutationTaster
Benign
D;D
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D;D
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
B;B
Vest4
MutPred
Gain of ubiquitination at K297 (P = 0.0378);.;
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at